![]() |
|
|
Vol. 287, Issue 1, 72-80, October 1998
Departments of
Pharmacology and Therapeutics (J.R.M., D.S., N.E.G.)
and
Psychiatry (N.E.G.), Louisiana State University Medical Center,
Shreveport, Louisiana
The effect of corticosterone on the acquisition of cocaine-seeking
behavior was investigated in rats using ascending dose-response curves
for intravenous cocaine self-administration. Rats pretreated daily with
corticosterone (2.0 mg/kg i.p.) acquired cocaine self-administration at
a lower dose compared with vehicle-treated controls. In contrast, daily
corticosterone pretreatment did not alter food-maintained responding.
Cocaine self-administration was not affected by the type I
(mineralocorticoid) receptor agonist, aldosterone (100 µg/kg).
However, rats treated with the type II (glucocorticoid) receptor
agonist, dexamethasone (10 or 100 µg/kg) did not acquire self-administration at any dose tested. The 100 µg/kg dose of dexamethasone attenuated food-reinforced behavior and decreased body
weight, but these effects were not observed with the 10 µg/kg dose.
Dexamethasone dose-dependently attenuated the plasma corticosterone response to self-administered infusions or intraperitoneal injections of cocaine, indicating that the ability of dexamethasone to block cocaine-induced corticosterone secretion may have contributed to its
effects on self-administration. Administration of aldosterone (100 µg/kg) together with 10 µg/kg dexamethasone restored
self-administration to the level of vehicle-treated rats, suggesting
that type I receptor occupation by corticosterone may be required for
the acquisition of this behavior. These results indicate that
stress-induced corticosterone secretion may provide a substrate through
which stressors interact with cocaine reinforcement. Additionally, the
finding that dexamethasone blocks the acquisition of cocaine
self-administration may be relevant to the development of novel
approaches to the treatment of cocaine addiction.
This article has been cited by other articles:
![]() |
Z. M. Fagen, R. Mitchum, P. Vezina, and D. S. McGehee Enhanced Nicotinic Receptor Function and Drug Abuse Vulnerability J. Neurosci., August 15, 2007; 27(33): 8771 - 8778. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Rasmusson, M. R. Picciotto, and S. Krishnan-Sarin Smoking as a complex but critical covariate in neurobiological studies of posttraumatic stress disorders: a review J Psychopharmacol, September 1, 2006; 20(5): 693 - 707. [Abstract] [PDF] |
||||
![]() |
M. C. Moffett, J. Harley, D. Francis, S. P. Sanghani, W. I. Davis, and M. J. Kuhar Maternal Separation and Handling Affects Cocaine Self-Administration in Both the Treated Pups as Adults and the Dams J. Pharmacol. Exp. Ther., June 1, 2006; 317(3): 1210 - 1218. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. E. Goeders Stress and Cocaine Addiction J. Pharmacol. Exp. Ther., June 1, 2002; 301(3): 785 - 789. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. D. Walker, R. Francis, J. Cabassa, and C. M. Kuhn Effect of Ovarian Hormones and Estrous Cycle on Stimulation of the Hypothalamo-Pituitary-Adrenal Axis by Cocaine J. Pharmacol. Exp. Ther., April 1, 2001; 297(1): 291 - 298. [Abstract] [Full Text] |
||||
![]() |
J. R. Mantsch, S. D. Schlussman, A. Ho, and M. J. Kreek Effects of Cocaine Self-Administration on Plasma Corticosterone and Prolactin in Rats J. Pharmacol. Exp. Ther., July 1, 2000; 294(1): 239 - 247. [Abstract] [Full Text] |
||||